Thaler Klaus, Kanneganti Shalini, Khajanchee Yashohdan, Wilson Charlyn, Swanstrom Lee, Hansen Paul D
Department of Hepatobiliary and Pancreatic Surgery, Legacy Health System, 1040 NW 22nd Avenue, Portland, OR 97210, USA.
Arch Surg. 2005 Aug;140(8):727-34. doi: 10.1001/archsurg.140.8.727.
Laparoscopy is an increasingly important tool in the staging and treatment of hepatic malignancies. This study evaluates the effect of staging laparoscopy (SL) using intraoperative ultrasonography (IOUS) on the regional treatment of isolated hepatic colorectal metastasis.
Analytic cohort study.
Tertiary care center.
Consecutive patients who have a colorectal metastasis confined to the liver and selected for surgical regional treatment.
All patients underwent preoperative evaluation followed by SL/IOUS. Operative plans were based on preoperative imaging and were either carried out or altered intraoperatively according to SL/IOUS findings.
Effect of SL/IOUS on surgical management.
Between September 1996 and May 2004 one hundred fifty-two SL/IOUSs were performed in 136 patients (77 males and 59 females), who had a mean (SD) age of 63 (11) years. Data sets were complete in 138 events. All patients had isolated hepatic disease as defined by preoperative computed tomography in 152 (100%) and positron emission tomography in 107 (70%). Staging laparoscopy/IOUS identified surgically untreatable disease in 34 events (25%) because of peritoneal metastases (n = 15), nodal involvement (n = 11), diffuse hepatic disease (n = 5), no identifiable disease (n = 2), and untreatable disease (n = 1). Laparoscopic treatment events included radiofrequency ablations (n = 78), hepatic artery pump implantations (n = 40), resections (n = 26), and combined procedures (n = 37). Overall, SL/IOUS changed the treatment plan in 66 (48%) of 138 of events. This includes 32 (23%) of 138 events in which SL/IOUS findings significantly altered the actual procedure performed relative to the preoperative plan. Three minor complications occurred in the SL/IOUS-only group with a mean (SD) hospital stay of 1.3 (1) days.
In the regional management of isolated colorectal hepatic metastasis, SL/IOUS avoids unnecessary laparotomies and influences definitive surgical intervention in a substantial proportion of patients.
腹腔镜检查在肝脏恶性肿瘤的分期和治疗中是一种日益重要的工具。本研究评估使用术中超声检查(IOUS)的分期腹腔镜检查(SL)对孤立性肝结直肠癌转移区域治疗的影响。
分析队列研究。
三级医疗中心。
连续入选的患有局限于肝脏的结直肠癌转移且选择进行手术区域治疗的患者。
所有患者均接受术前评估,随后进行SL/IOUS。手术方案基于术前影像学检查,并根据SL/IOUS的结果在术中实施或更改。
SL/IOUS对手术管理的影响。
1996年9月至2004年5月期间,对136例患者(77例男性和59例女性)进行了152次SL/IOUS,患者的平均(标准差)年龄为63(11)岁。138例事件的数据集完整。所有患者术前计算机断层扫描均显示为152例(100%)孤立性肝脏疾病,正电子发射断层扫描显示为107例(70%)。分期腹腔镜检查/IOUS在34例事件(25%)中发现了无法手术治疗的疾病,原因包括腹膜转移(n = 15)、淋巴结受累(n = 11)、弥漫性肝脏疾病(n = 5)、未发现可识别的疾病(n = 2)以及无法治疗的疾病(n = 1)。腹腔镜治疗事件包括射频消融(n = 78)、肝动脉泵植入(n = 40)、切除术(n = 26)和联合手术(n = 37)。总体而言,SL/IOUS在138例事件中的66例(48%)中改变了治疗方案。这包括138例事件中的32例(23%),其中SL/IOUS的结果相对于术前计划显著改变了实际实施的手术。仅进行SL/IOUS的组发生了3例轻微并发症,平均(标准差)住院时间为1.3(1)天。
在孤立性结直肠癌肝转移的区域管理中,SL/IOUS避免了不必要的开腹手术,并在相当一部分患者中影响了确定性手术干预。